GSK EPS - Earnings per Share 2010-2024 | GSK

GSK earnings per share (EPS) for the twelve months ending September 30, 2024 was $1.53, a 64.32% decline year-over-year.

  • GSK EPS for the quarter ending September 30, 2024 was $-0.04, a 104% decline year-over-year.
  • GSK 2023 annual EPS was $2.98, a 67.08% decline from 2022.
  • GSK 2022 annual EPS was $9.06, a 200.9% increase from 2021.
  • GSK 2021 annual EPS was $3.01, a 17.8% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

GSK EPS - Earnings per Share 2010-2024 | GSK

  • GSK EPS for the quarter ending September 30, 2024 was $-0.04, a 104% decline year-over-year.
  • GSK 2023 annual EPS was $2.98, a 67.08% decline from 2022.
  • GSK 2022 annual EPS was $9.06, a 200.9% increase from 2021.
  • GSK 2021 annual EPS was $3.01, a 17.8% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.